[Olaparib for metastatic prostate cancer-the PROfound trial]

Urologe A. 2020 Oct;59(10):1249-1250. doi: 10.1007/s00120-020-01306-6.
[Article in German]
No abstract available

MeSH terms

  • Humans
  • Male
  • Phthalazines*
  • Piperazines
  • Prostatic Neoplasms* / drug therapy

Substances

  • Phthalazines
  • Piperazines
  • olaparib